July 24, 2009 - Biotronics3D has worked with The Institute of Cancer Research (ICR) to develop and launch new software called 3D Net Perfusion, a system that extracts data from images of tumors and transforms it into usable information.
Designed to significantly improve the accuracy of MRI scan analysis, 3D Net Perfusion aims to enable clinicians to gain clearer comprehension of MRI scans, improving the accuracy of diagnosis and assessment of treatment efficacy. It is also an innovative way of visualising and measuring the blood supply to cancers – a crucial factor in tumour growth.
The software is the result of pioneering trials at the ICR led by Professor Martin Leach, David Collins and James d’Arcy, and is currently used in 10 research centers. Scientists from the ICR continue to work with Biotronics3D software developers to further enhance the product.
For more information: www.icr.ac.uk and www.biotronics3d.com
August 21, 2026 
